Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Effects of Motivational Interviewing on Pain Self-Efficacy and Exercise Behavior in Individuals With Knee Osteoarthritis

14 de agosto de 2026 atualizado por: Ismail Saracoglu, Kutahya Health Sciences University

Investigation of the Effects of Motivational Interviewing on Pain Self-Efficacy and Exercise Behavior in Individuals With Knee Osteoarthritis

This randomized controlled trial aims to investigate the effects of motivational interviewing added to a neuromuscular exercise and home exercise program on pain self-efficacy, exercise behavior, pain intensity, physical performance, and functional status in individuals with knee osteoarthritis. Sixty individuals diagnosed with knee osteoarthritis will be randomly allocated to either an intervention group or a control group. The intervention group will receive motivational interviewing in addition to neuromuscular exercise and a home exercise program, whereas the control group will receive neuromuscular exercise and the same home exercise program. Outcomes will be assessed at baseline, immediately after the intervention, and six weeks after the intervention.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Estimado)

56

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

    • Türkiye
      • Afyonkarahisar, Türkiye, Turquia (Türkiye), 03100
        • Recrutamento
        • AFSÜ Health Application and Research Center, Department of Physical Therapy and Rehabilitation
        • Contato:
        • Investigador principal:
          • İbrahim YUKSEL, Msc.
        • Investigador principal:
          • Ismail Saracoglu, Phd
        • Subinvestigador:
          • Nuray EYVAZ, MD

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Diagnosis of knee osteoarthritis according to American College of Rheumatology (ACR) criteria
  • Kellgren-Lawrence radiographic grade ≥2
  • Knee pain lasting longer than 3 months

Exclusion Criteria:

  • History of joint arthroplasty
  • Body mass index >40 kg/m²
  • Neuromuscular or neurological diseases such as stroke, Parkinson's disease, or multiple sclerosis
  • History of lower-extremity joint fracture
  • Hip osteoarthritis

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Dobro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Motivational Interviewing + Neuromuscular Exercise + Home Exercise
Participants in this group will receive motivational interviewing in addition to a supervised neuromuscular exercise program and a home exercise program.
Motivational interviewing will be delivered individually in face-to-face sessions by a researcher trained and certified in motivational interviewing. Sessions will focus on identifying individual barriers and goals, strengthening motivation and commitment to exercise, supporting self-efficacy, and preventing relapse. The intervention will incorporate three stages: increasing exercise motivation, strengthening commitment to exercise, and relapse prevention.
Participants will perform neuromuscular exercise sessions five times per week for four weeks. Each 60-minute session will consist of approximately 10 minutes of warm-up, 40 minutes of exercise, and 10 minutes of cool-down. Exercises will include core stabilization and postural control, postural orientation, lower-extremity strengthening, functional exercises, and balance and proprioception exercises. Exercises will be progressed according to participant tolerance and functional performance.
The home exercise program will include isometric strengthening exercises for the quadriceps and hip adductor muscles, straight leg raising, assisted hip and knee flexion, and active knee flexion exercises. Participants will perform the program five days per week, twice daily, for three weeks, with 10 repetitions of each exercise. The program will be explained and demonstrated by a physiotherapist during the first session, and adherence will be followed by telephone contact.
Comparador Ativo: Neuromuscular Exercise Program
Participants will perform neuromuscular exercise sessions five times per week for four weeks. Each 60-minute session will consist of approximately 10 minutes of warm-up, 40 minutes of exercise, and 10 minutes of cool-down. Exercises will include core stabilization and postural control, postural orientation, lower-extremity strengthening, functional exercises, and balance and proprioception exercises. Exercises will be progressed according to participant tolerance and functional performance.
Participants will perform neuromuscular exercise sessions five times per week for four weeks. Each 60-minute session will consist of approximately 10 minutes of warm-up, 40 minutes of exercise, and 10 minutes of cool-down. Exercises will include core stabilization and postural control, postural orientation, lower-extremity strengthening, functional exercises, and balance and proprioception exercises. Exercises will be progressed according to participant tolerance and functional performance.
The home exercise program will include isometric strengthening exercises for the quadriceps and hip adductor muscles, straight leg raising, assisted hip and knee flexion, and active knee flexion exercises. Participants will perform the program five days per week, twice daily, for three weeks, with 10 repetitions of each exercise. The program will be explained and demonstrated by a physiotherapist during the first session, and adherence will be followed by telephone contact.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
The Exercise Self-Efficacy Scale (ESE)
Prazo: Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention
The Exercise Self-Efficacy Scale (ESE) measures a person's confidence in their ability to maintain regular physical activity or exercise when facing various internal and external barriers. Different validated versions exist, including Albert Bandura's 18-item scale, an older adult 9-item scale, and a 10-item spinal cord injury adaptation.
Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention
Pain Self-Efficacy Questionnaire (PSEQ)
Prazo: Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention
The Pain Self-Efficacy Questionnaire (PSEQ) is a 10-item self-report tool designed to measure a person's confidence in performing daily activities and functioning normally despite ongoing chronic pain. It uses a 7-point scale from 0 to 6, yielding total scores between 0 and 60, where higher scores reflect stronger coping confidence.
Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Numerical Pain Rating Scale
Prazo: Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention
The Numeric Pain Rating Scale (NPRs) is a fast, 11-point tool used to measure pain intensity. Patients select a whole number from 0 (no pain) to 10 (worst pain imaginable) to rate their discomfort verbally or in writing.
Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention
The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index)
Prazo: Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention.
The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) is a widely used, self-administered 24-item questionnaire that evaluates pain (5 items), stiffness (2 items), and physical function (17 items) in patients with knee or hip osteoarthritis.
Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention.
Physical Performance 30-Second Sit-to-Stand Test (30s STS)
Prazo: Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention
The 30s STS measures lower-extremity functional strength by recording the total number of complete sit-to-stand repetitions performed within 30 seconds, with a higher number of repetitions indicating better performance.
Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention
Physical performance timed up and go test (TUG)
Prazo: Baseline, immediately after 4 week intervention and 6 weeks after competition of the intervention
The TUG measures functional mobility as the time, in seconds, required to stand up from a chair, walk 3 meters, turn, walk back, and sit down, with a shorter completion time indicating better performance.
Baseline, immediately after 4 week intervention and 6 weeks after competition of the intervention
Physical performance 40-meter Walking Test
Prazo: Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention
The 40mWT assesses walking speed by recording the time required to complete a 40-meter walking course, with a shorter completion time indicating better walking performance. The results of the three tests will be reported separately and will not be combined into a composite score.
Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de fevereiro de 2026

Conclusão Primária (Estimado)

15 de novembro de 2026

Conclusão do estudo (Estimado)

31 de dezembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

11 de agosto de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

14 de agosto de 2026

Primeira postagem (Real)

17 de agosto de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

17 de agosto de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

14 de agosto de 2026

Última verificação

1 de agosto de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever